TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8554941

Group type: EXPERIMENTAL
Intervention: Ethanol 0.3 g kg-1 before an evening meal
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ethanol 0.3 g kg-1 after an evening meal
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fasted subjects
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fed subjects
Number of subjects: 24
Study: 2231825

Group type: EXPERIMENTAL
Intervention: Cranial electrostimulation (CES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 0
Study: 6105520

Group type: EXPERIMENTAL
Intervention: Human insulin (low dose)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Human insulin (high dose)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Porcine insulin (low dose)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Porcine insulin (high dose)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Human insulin (intravenous infusion)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Porcine insulin (intravenous infusion)
Number of subjects: 11
Study: 30704694

Group type: EXPERIMENTAL
Intervention: Temperature-controlled Laminar Airflow (TLA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 29134299

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 34
Study: 26603627

Group type: EXPERIMENTAL
Intervention: Gain-framed message promoting dietary calcium consumption
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Loss-framed message promoting calcium supplements
Number of subjects: 288

Group type: COMPARATOR
Intervention: Gain-framed message
Number of subjects: 288

Group type: COMPARATOR
Intervention: Loss-framed message
Number of subjects: 288
Study: 24600218

Group type: EXPERIMENTAL
Intervention: Self-management intervention (details not specified)
Number of subjects: 15
Study: 22972835

Group type: EXPERIMENTAL
Intervention: Short sleep (4 h/night; 0100‐0500 h)
Number of subjects: 27
Study: 20806117

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice daily
Number of subjects: 1715

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg once daily
Number of subjects: 1715

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg twice daily
Number of subjects: 1715

Group type: EXPERIMENTAL
Intervention: Apixaban 20 mg once daily
Number of subjects: 1715

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1715
Study: 17408867

Group type: EXPERIMENTAL
Intervention: Anxious mood condition for CM-anxiety participants
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Positive mood condition for EM participants
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positive mood condition for CM-anxiety participants
Number of subjects: 48

Group type: COMPARATOR
Intervention: Anxious mood condition for EM participants
Number of subjects: 48
Study: 15822418

Group type: EXPERIMENTAL
Intervention: Sufentanil TCI (0.08-0.1 ng/ml)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sufentanil TCI
Number of subjects: 26

Group type: COMPARATOR
Intervention: i.v. morphine (Bolus group)
Number of subjects: 26
Study: 11875316

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (Normotensives)
Number of subjects: 22
Study: 11337713

Group type: EXPERIMENTAL
Intervention: Ropivacaine 75 mg in 20 mL of saline solution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Morphine 2 mg in 20 mL of saline solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline solution 20 mL
Number of subjects: 90
Study: 9672330

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily for 8 weeks
Number of subjects: 9
Study: 8790529

Group type: EXPERIMENTAL
Intervention: Tailored letter
Number of subjects: 3083

Group type: COMPARATOR
Intervention: Standard letter
Number of subjects: 3083
Study: 2742729

Group type: EXPERIMENTAL
Intervention: 5 mg d-amphetamine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20 mg d-amphetamine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 181258

Group type: EXPERIMENTAL
Intervention: Intravenous Intralipid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous egg phospholipid
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intragastric Intralipid
Number of subjects: 8
Study: 30910373

Group type: EXPERIMENTAL
Intervention: NAE (Net Acid Excretion) measurement
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Demographics, body composition, laboratory values (including eGFR and serum bicarbonate level)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Insulin resistance, dietary potential renal acid load, and metabolically active medications (e.g., metformin, allopurinol, nonstatin lipid agents)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Body size indicators (body surface area, body mass index, fat-free mass)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Race/ethnicity and eGFR
Number of subjects: 978
Study: 28549783

Group type: EXPERIMENTAL
Intervention: irinotecan-temozolomide-dinutuximab
Number of subjects: 35

Group type: COMPARATOR
Intervention: irinotecan-temozolomide-temsirolimus
Number of subjects: 35
Study: 25939101

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) whole-body calisthenics
Number of subjects: 26

Group type: COMPARATOR
Intervention: Typical physical training
Number of subjects: 26
Study: 22956683

Group type: EXPERIMENTAL
Intervention: Implementation intentions (writing down when, where, and how to increase fruit and vegetable intake)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 208
Study: 21788003

Group type: EXPERIMENTAL
Intervention: Karydakis flap
Number of subjects: 269

Group type: COMPARATOR
Intervention: Limberg flap
Number of subjects: 269
Study: 19570486

Group type: EXPERIMENTAL
Intervention: Self-management program
Number of subjects: 0
Study: 16688811

Group type: EXPERIMENTAL
Intervention: 3‐DCRT combined with FOLFOX4 chemotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: 3‐DCRT
Number of subjects: 48
Study: 15196613

Group type: EXPERIMENTAL
Intervention: Trials with the largest effect sizes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Trials with the smallest effect sizes
Number of subjects: 25
Study: 11304939

Group type: EXPERIMENTAL
Intervention: Dimetindene 0.1% (Fenistil Nasal Spray)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Levocabastine 0.05% solution
Number of subjects: 100
Study: 9322630

Group type: EXPERIMENTAL
Intervention: Active management of labor
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Active management of labor with epidural analgesics
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care control protocol
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care control protocol with epidural analgesics
Number of subjects: 405
Study: 8140565

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (E) 25‐50 mg per day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of altizide 15 mg and aldactone 25 mg (A) 1 or 2 tablets per day
Number of subjects: 28
Study: 10279100

Group type: EXPERIMENTAL
Intervention: Self-instruction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 31311674

Group type: EXPERIMENTAL
Intervention: Rimegepant (75 mg orally disintegrating tablet)
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1466
Study: 27860023

Group type: EXPERIMENTAL
Intervention: Computer color-matching (CCM) system based on the improved back-propagation neural network (BPNN) model
Number of subjects: 43

Group type: COMPARATOR
Intervention: Traditional visual method
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Color distributions (ΔL*, Δa*, and Δb*)
Number of subjects: 43
Study: 26784651

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 5107

Group type: EXPERIMENTAL
Intervention: Marine omega-3 FA (1g/day)
Number of subjects: 5107

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 5107
Study: 25172891

Group type: EXPERIMENTAL
Intervention: Steady-state increases in P ET , CO 2 of 5 and 10 Torr above baseline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rebreathing-induced transient breath-by-breath increases in P ET , CO 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hyperventilation for 1 min followed by rebreathing
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rebreathing only
Number of subjects: 8
Study: 22244381

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 3265

Group type: COMPARATOR
Intervention: Thrombolysis In Myocardial Infarction grade 3 flow after PCI
Number of subjects: 3265
Study: 20225536

Group type: EXPERIMENTAL
Intervention: Budesonide (200 microg/puff, 2 puffs/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fluticasone propionate (250 microg/puff, 2 puffs/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 14
Study: 16718285

Group type: EXPERIMENTAL
Intervention: Stunted participants
Number of subjects: 167

Group type: COMPARATOR
Intervention: Non-stunted participants
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Stunted participants with greater increases in height-for-age
Number of subjects: 167
Study: 16249460

Group type: EXPERIMENTAL
Intervention: Troglitazone (TZD)
Number of subjects: 93
Study: 12925484

Group type: EXPERIMENTAL
Intervention: Remifentanil (2 microg kg(‐1) over 30 s)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alfentanil (30 microg kg(‐1) over 30 s)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 60
Study: 10678439

Group type: EXPERIMENTAL
Intervention: Early revascularization (within 4 weeks)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Delayed symptom-driven revascularization
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Attempted revascularization of > or = 66% of vessels with significant stenosis
Number of subjects: 262
Study: 8767563

Group type: EXPERIMENTAL
Intervention: 7.5 mg midazolam
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 20 mg clorazepate dipotassium
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 1684196

Group type: EXPERIMENTAL
Intervention: Cefuroxime (iv)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (iv or oral)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 0
Study: 6356321

Group type: EXPERIMENTAL
Intervention: Sucralfate, 1 g four times daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cimetidine, 200 mg three times daily and 400 mg at night
Number of subjects: 80
Study: 3989877

Group type: EXPERIMENTAL
Intervention: Guided imagery of a female initiating a sexual invitation and being assertive during coitus
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Guided imagery of a male initiating a sexual invitation and being assertive during coitus
Number of subjects: 138
Study: 28924075

Group type: EXPERIMENTAL
Intervention: Physiotherapy plus 30 mg/day edoxaban
Number of subjects: 38

Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 38
Study: 27790530

Group type: EXPERIMENTAL
Intervention: Evidence Based Protocol (EBP)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 226
Study: 24219512

Group type: EXPERIMENTAL
Intervention: Group 1 (List A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group 2 (List B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: List A
Number of subjects: 200

Group type: COMPARATOR
Intervention: List B
Number of subjects: 200
Study: 22349389

Group type: COMPARATOR
Intervention: Avandia (group B)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Puerarin combined with avandia (group C)
Number of subjects: 180
Study: 20575165

Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-I)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-II)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard training (ST)
Number of subjects: 53
Study: 18156406

Group type: EXPERIMENTAL
Intervention: Folate intake of 438 microg DFE/d for 12 weeks
Number of subjects: 60
Study: 16628625

Group type: EXPERIMENTAL
Intervention: 30-mg clevudine
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 50-mg clevudine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 11158463

Group type: EXPERIMENTAL
Intervention: Variable flow nasal CPAP
Number of subjects: 32

Group type: COMPARATOR
Intervention: Modified nasal cannula
Number of subjects: 32

Group type: COMPARATOR
Intervention: CPAP prongs
Number of subjects: 32
Study: 9545990

Group type: EXPERIMENTAL
Intervention: Hydromorphone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Butorphanol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 9
Study: 8281852

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 99
Study: 2738757

Group type: EXPERIMENTAL
Intervention: Special breast cleansing before breast pumping
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (thorough hand washing only)
Number of subjects: 65
Study: 4909360

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (administered orally for 3 days)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo linctus (administered orally for 3 days)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo linctus
Number of subjects: 51
Study: 31884682

Group type: EXPERIMENTAL
Intervention: Telephone health coaching for 12 months
Number of subjects: 1535

Group type: COMPARATOR
Intervention: Usual health care and long-term care (LTC)
Number of subjects: 1535
Study: 29185675

Group type: EXPERIMENTAL
Intervention: Muscle stretching exercises
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 27186571

Group type: EXPERIMENTAL
Intervention: Mutaf technique
Number of subjects: 81

Group type: COMPARATOR
Intervention: Limberg flap
Number of subjects: 81
Study: 24708570

Group type: EXPERIMENTAL
Intervention: Workplace-based physical exercise (5x10 minutes per week for 10 weeks, using kettlebells, elastic bands, and exercise balls)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Home-based physical exercise (5x10 minutes per week for 10 weeks, using elastic bands and body weight exercises)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups received ergonomic instructions on patient handling and use of lifting aides.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 22417197

Group type: EXPERIMENTAL
Intervention: FRIENDS for life program (manualized individual cognitive behavioral treatment)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: TPOCS‐A (observer-rated youth alliance measure)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Child-therapist alliance ratings
Number of subjects: 52
Study: 20861377

Group type: EXPERIMENTAL
Intervention: Hydrocortisone administered 75 min before scanning
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Hydrocortisone administered 285 min before scanning
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 18524784

Group type: EXPERIMENTAL
Intervention: BIS-40
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: BIS-50
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: BIS-60
Number of subjects: 84
Study: 15853098

Group type: EXPERIMENTAL
Intervention: saline solution
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: ferric sulfate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: calcium hydroxide (control group)
Number of subjects: 25
Study: 12362968

Group type: EXPERIMENTAL
Intervention: CRAFT
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CRAFT + aftercare
Number of subjects: 90

Group type: COMPARATOR
Intervention: Al‐Nar FT
Number of subjects: 90
Study: 10435146

Group type: EXPERIMENTAL
Intervention: Oral Balance gel and Biotene toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (carboxymethylcellulose gel and commercial toothpaste)
Number of subjects: 0
Study: 7852526

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg.day gallium nitrate
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg.day gallium nitrate
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg.day gallium nitrate
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 49
Study: 2087618

Group type: EXPERIMENTAL
Intervention: Nifluril (400 mg daily, morniflumate)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Amoxicilline (50 mg/kg daily)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 358728

Group type: EXPERIMENTAL
Intervention: Rivanol alone
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: PGF2alpha alone
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Rivanol combined with PGF2alpha
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Rivanol combined with half dose PGF2alpha
Number of subjects: 92

Group type: COMPARATOR
Intervention: Rivanol
Number of subjects: 92

Group type: COMPARATOR
Intervention: PGF2alpha
Number of subjects: 92
Study: 29557414

Group type: EXPERIMENTAL
Intervention: Probiotic 'Symbiter' (14 probiotic bacteria genera)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Probiotic 'Symbiter'
Number of subjects: 58
Study: 26489835

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) twice daily for 2 weeks at 30% of maximal inspiratory pressure, in addition to standard postoperative physiotherapy.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard physiotherapy (breathing exercises, coughing techniques, early mobilization)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 68
Study: 24944159

Group type: EXPERIMENTAL
Intervention: Bosutinib 500 mg/d
Number of subjects: 502

Group type: COMPARATOR
Intervention: Imatinib 400 mg/d
Number of subjects: 502
Study: 22339611

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of CBT and SSRIs
Number of subjects: 0
Study: 20730073

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both treatments (Candesartan and CCBs)
Number of subjects: 53
Study: 17089413

Group type: EXPERIMENTAL
Intervention: Dissonance intervention
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 15192693

Group type: EXPERIMENTAL
Intervention: Pressure phosphene tonometry using Proview eye pressure monitor
Number of subjects: 100

Group type: COMPARATOR
Intervention: Goldmann tonometry
Number of subjects: 100
Study: 11892706

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg BID for 6 weeks (OA)
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Diclofenac 50 mg BID or TID for 6 weeks (OA)
Number of subjects: 1711

Group type: COMPARATOR
Intervention: Placebo for 6 weeks (OA)
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg BID for 24 weeks (RA)
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg BID for 24 weeks (RA)
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Celecoxib (both OA and RA)
Number of subjects: 1711
Study: 10333347

Group type: EXPERIMENTAL
Intervention: valsartan 10 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: valsartan 40 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: valsartan 160 mg
Number of subjects: 122

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 122
Study: 7795831

Group type: EXPERIMENTAL
Intervention: Weight loss alone
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Sodium reduction alone
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Combination of weight loss and sodium reduction
Number of subjects: 2382

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2382
Study: 1799913

Group type: EXPERIMENTAL
Intervention: rDNA HI (BY)
Number of subjects: 65

Group type: COMPARATOR
Intervention: ssHI
Number of subjects: 65
Study: 6992260

Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy without drainage (HSV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective vagotomy with pyloroplasty (SV)
Number of subjects: 0
Study: 31775668

Group type: EXPERIMENTAL
Intervention: Individualized psychotherapy starting prenatal and lasting for 10 months
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention following psychotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group of healthy women
Number of subjects: 100
Study: 28525534

Group type: EXPERIMENTAL
Intervention: Three cycles of docetaxel followed by three cycles of fluorouracil, epirubicin and cyclophosphamide once every 21 days with four cycles of bevacizumab
Number of subjects: 800

Group type: COMPARATOR
Intervention: Three cycles of docetaxel followed by three cycles of fluorouracil, epirubicin and cyclophosphamide once every 21 days without bevacizumab
Number of subjects: 800
Study: 25915145

Group type: EXPERIMENTAL
Intervention: Precut Kinesiology Tape (PCT) and Exercise (n = 33)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NSAID and Exercise (n = 29)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Exercise only (n = 38)
Number of subjects: 100
Study: 24477242

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12